Stocks
YD Bio LtdYDES
NASDAQHealthcareBiotechnology$4.95
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders, with a focus on rare disease indications. Its pipeline includes early-stage candidates targeting conditions with limited treatment options, and investors track it for potential regulatory milestones and partnership opportunities.
52W Range: $1.70-$18.57
Congressional Interest in YD Bio Ltd (YDES)
No congressional trades have been disclosed for YD Bio Ltd (YDES) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading YDES?
No congressional trades found for this stock.